Editorial: Reviews in pediatric primary immunodeficiencies.
作者信息
Kilic Sara Sebnem
机构信息
Department of Pediatric Immunology and Rheumatology, Bursa Uludag University Faculty of Medicine, Bursa, Türkiye.
出版信息
Front Pediatr. 2025 Mar 26;13:1588443. doi: 10.3389/fped.2025.1588443. eCollection 2025.
Abstract
摘要
相似文献
1
Editorial: Reviews in pediatric primary immunodeficiencies.社论：儿科原发性免疫缺陷综述
Front Pediatr. 2025 Mar 26;13:1588443. doi: 10.3389/fped.2025.1588443. eCollection 2025.
2
IKAROS-Associated Diseases in 2020: Genotypes, Phenotypes, and Outcomes in Primary Immune Deficiency/Inborn Errors of Immunity.2020 年 IKAROS 相关疾病：原发性免疫缺陷/先天性免疫错误中的基因型、表型和结局。
J Clin Immunol. 2021 Jan;41(1):1-10. doi: 10.1007/s10875-020-00936-x. Epub 2021 Jan 3.
3
Inborn errors of human IKAROS: LOF and GOF variants associated with primary immunodeficiency.人类 IKAROS 的先天性错误：与原发性免疫缺陷相关的 LO F 和 GOF 变体。
Clin Exp Immunol. 2023 Apr 25;212(2):129-136. doi: 10.1093/cei/uxac109.
4
Severity of SARS-CoV-2 infection in children with inborn errors of immunity (primary immunodeficiencies): a systematic review.患有先天性免疫缺陷（原发性免疫缺陷）儿童的新型冠状病毒2型感染严重程度：一项系统评价
Allergy Asthma Clin Immunol. 2023 Aug 9;19(1):69. doi: 10.1186/s13223-023-00831-1.
5
IgG4-related disease and B-cell malignancy due to an IKZF1 gain-of-function variant.由于 IKZF1 功能获得性变异导致的 IgG4 相关疾病和 B 细胞恶性肿瘤。
J Allergy Clin Immunol. 2024 Sep;154(3):819-826. doi: 10.1016/j.jaci.2024.03.018. Epub 2024 Apr 4.
6
Germline mutations and their impact on immunity: IKAROS-associated diseases and pathophysiology.胚系突变及其对免疫的影响：IKAROS 相关疾病及其病理生理学。
Expert Rev Clin Immunol. 2021 Apr;17(4):407-416. doi: 10.1080/1744666X.2021.1901582. Epub 2021 Mar 19.
7
Primary immunodeficiencies underlying fungal infections.导致真菌感染的原发性免疫缺陷病。
Curr Opin Pediatr. 2013 Dec;25(6):736-47. doi: 10.1097/MOP.0000000000000031.
8
[Registry of Inborn errors of immunity in a pediatric hospital].[一家儿科医院的先天性免疫缺陷登记处]
Rev Alerg Mex. 2020 Jul-Sep;67(3):268-278. doi: 10.29262/ram.v67i3.738.
9
IKAROS protein stability is regulated by its early N-terminal region and C-terminal dimerization domain.IKAROS蛋白的稳定性受其早期N端区域和C端二聚化结构域调控。
Clin Immunol. 2025 May;274:110469. doi: 10.1016/j.clim.2025.110469. Epub 2025 Feb 28.
10
Ikaros-Associated Diseases: From Mice to Humans and Back Again.与伊卡洛斯相关的疾病：从小鼠到人类，再回归小鼠
Front Pediatr. 2021 Jul 16;9:705497. doi: 10.3389/fped.2021.705497. eCollection 2021.
本文引用的文献
1
Autoinflammatory Diseases/Periodic Fevers.自身炎症性疾病/周期性发热。
Pediatr Rev. 2023 Sep 1;44(9):481-490. doi: 10.1542/pir.2022-005635.
2
Can Ikaros mutation lead to intellectual disability?IKAROS基因突变会导致智力残疾吗？
Scand J Immunol. 2022 Apr;95(4):e13138. doi: 10.1111/sji.13138. Epub 2022 Jan 17.
3
Real-World Experiences With Facilitated Subcutaneous Immunoglobulin Substitution in Patients With Hypogammaglobulinemia, Using a Three-Step Ramp-Up Schedule.利用三步爬坡方案，在接受皮下免疫球蛋白替代治疗的低丙种球蛋白血症患者中获得的真实世界经验。
Front Immunol. 2021 Apr 27;12:670547. doi: 10.3389/fimmu.2021.670547. eCollection 2021.
4
IKAROS-Associated Diseases in 2020: Genotypes, Phenotypes, and Outcomes in Primary Immune Deficiency/Inborn Errors of Immunity.2020 年 IKAROS 相关疾病：原发性免疫缺陷/先天性免疫错误中的基因型、表型和结局。
J Clin Immunol. 2021 Jan;41(1):1-10. doi: 10.1007/s10875-020-00936-x. Epub 2021 Jan 3.
5
Efficacy, safety, tolerability and pharmacokinetics of a novel human immune globulin subcutaneous, 20%: a Phase 2/3 study in Europe in patients with primary immunodeficiencies.新型20%皮下注射用人免疫球蛋白的疗效、安全性、耐受性及药代动力学：在欧洲针对原发性免疫缺陷患者开展的2/3期研究
Clin Exp Immunol. 2017 Jan;187(1):146-159. doi: 10.1111/cei.12866. Epub 2016 Oct 18.
6
Chronic granulomatous disease.慢性肉芽肿病
Br Med Bull. 2016 Jun;118(1):50-63. doi: 10.1093/bmb/ldw009. Epub 2016 Mar 16.
7
Primary immunodeficiencies worldwide: an updated overview from the Jeffrey Modell Centers Global Network.全球原发性免疫缺陷病：杰弗里·莫德尔中心全球网络的最新综述
Immunol Res. 2016 Jun;64(3):736-53. doi: 10.1007/s12026-016-8784-z.
8
Practice parameter for the diagnosis and management of primary immunodeficiency.原发性免疫缺陷病的诊断和管理实践参数。
J Allergy Clin Immunol. 2015 Nov;136(5):1186-205.e1-78. doi: 10.1016/j.jaci.2015.04.049. Epub 2015 Sep 12.
9
Progress in gammaglobulin therapy for immunodeficiency: from subcutaneous to intravenous infusions and back again.免疫缺陷症的丙种球蛋白治疗进展：从皮下注射到静脉输注，再到回归。
J Clin Immunol. 2012 Dec;32(6):1153-64. doi: 10.1007/s10875-012-9740-x. Epub 2012 Jul 25.
Zotero 插件